The Pet Cancer Therapeutics Market is experiencing strong momentum driven by advancements in veterinary oncology and rising prevalence of cancer in companion animals. The market’s dynamics are shaped by cutting-edge drug developments and growing awareness among pet owners about cancer treatment options. Strategic innovations in targeted therapies and immuno-oncology are notably...